Victor Bartsevich Email Address

Director of Emerging Technologies Development

Precision BioSciences, Inc., a biotechnology company, engages in developing and commercializing therapeutics and services based on genomic molecular biology.

Ph.D. Biologist with 20 years of biotechnology industry experience with focus on the development of gene editing technologies and CAR-T therapies. Extensive hands-on expertise in molecular and cell biology methods, assay development, protein engineering and molecular evolution. Expert level in combinatorial library approaches for selection and optimization of proteins for therapeutic applications. Specialties: biotechnology; molecular biology; protein engineering; assay development; directed molecular evolution; phage display and other selection methods; development of gene editing technologies and therapies; development of nucleases and corresponding specificity assays; development of cell therapies (CAR-Ts); development of human antibodies (single chain and single domain or nanobodies, TCR-like antibodies, bi-specifics, CD3-engagers) for targeting of cancer antigens associated with blood and solid tumors.